In addition, breast cancer cells transfected with miR-1208 mimics or miR-1208 inhibitors were able to completely reverse the effect of TMEM105 overexpression or knockdown on OS time in the mice (Fig. 7H, I). Here, TMEM105 is linked to breast cancer.